![](https://partners4access.com/wp-content/uploads/2018/05/shutterstock_709781044-1-300x169.jpeg)
Whitepapers
What does the new FDA accelerated regulatory pathway mean for gene therapies?
U.S. Food and Drug Administration (FDA) commissioner Scott Gottlieb has announced that the drug agency is developing a system by which innovative gene therapies could